Dual strands of the miR-223 duplex (miR-223-5p and miR-223-3p) inhibit cancer cell aggressiveness: targeted genes are involved in bladder cancer pathogenesis

miR-223 is repressed and correlates with inferior clinical features in mantle cell lymphoma through targeting SOX11

(2018) Keshu Zhou et al.   EXPERIMENTAL HEMATOLOGY

Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends

(2017) Sebastien Antoni et al.   EUROPEAN UROLOGY

The role of miRNA-223 in cancer: Function, diagnosis and therapy

(2017) Yunliang Gao et al.   GENE

miR-223 potentially targets SWI/SNF complex protein SMARCD1 in atypical proliferative serous tumor and high-grade ovarian serous carcinoma

(2017) Florence A. Arts et al.   HUMAN PATHOLOGY

Dual Strands of Pre-miR-149 Inhibit Cancer Cell Migration and Invasion through Targeting FOXM1 in Renal Cell Carcinoma

(2017) Atsushi Okato et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

MiR-223/PAX6 Axis Regulates Glioblastoma Stem Cell Proliferation and the Chemo Resistance to TMZ via Regulating PI3K/Akt Pathway

(2017) Bai-Sheng Huang et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Regulation of HMGB3 by antitumor miR-205-5p inhibits cancer cell aggressiveness and is involved in prostate cancer pathogenesis

(2017) Yasutaka Yamada et al.   JOURNAL OF HUMAN GENETICS

Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs

(2017) Keiichi Koshizuka et al.   Oncotarget

Regulation of actin-binding protein ANLN by antitumor miR-217 inhibits cancer cell aggressiveness in pancreatic ductal adenocarcinoma

(2017) Tetsuya Idichi et al.   Oncotarget

The microRNA expression signature of pancreatic ductal adenocarcinoma by RNA sequencing: anti-tumour functions of the microRNA-216 cluster

(2017) Keiichi Yonemori et al.   Oncotarget

Overexpression of Anillin (ANLN) is correlated with colorectal cancer progression and poor prognosis

(2016) Guanghui Wang et al.   Cancer Biomarkers

Dual tumor-suppressorsmiR-139-5pandmiR-139-3ptargetingmatrix metalloprotease 11in bladder cancer

(2016) Masaya Yonemori et al.   CANCER SCIENCE

The emerging role of miR-223 as novel potential diagnostic and therapeutic target for inflammatory disorders

(2016) Faisal Aziz   CELLULAR IMMUNOLOGY

The microRNA signatures: aberrantly expressed microRNAs in head and neck squamous cell carcinoma

(2016) Keiichi Koshizuka et al.   JOURNAL OF HUMAN GENETICS

Recent trends in microRNA research into breast cancer with particular focus on the associations between microRNAs and intrinsic subtypes

(2016) Sasagu Kurozumi et al.   JOURNAL OF HUMAN GENETICS

MicroRNA in pancreatic cancer

(2016) Keiichi Yonemori et al.   JOURNAL OF HUMAN GENETICS

Noncoding RNA and colorectal cancer: its epigenetic role

(2016) Yoshiaki Kita et al.   JOURNAL OF HUMAN GENETICS

Regulation of UHRF1 by dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p): inhibition of bladder cancer cell aggressiveness

(2016) Ryosuke Matsushita et al.   Oncotarget

Dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p) coordinately targeted MTDH in lung squamous cell carcinoma

(2016) Hiroko Mataki et al.   Oncotarget

High-Risk Non-Muscle-Invasive Bladder Cancer—Therapy Options During Intravesical BCG Shortage

(2016) Rajan Veeratterapillay et al.   Current Urology Reports

Update on the management of non-muscle invasive bladder cancer

(2016) Saad Aldousari et al.   CUAJ-Canadian Urological Association Journal

MicroRNA expression signature of oral squamous cell carcinoma: functional role of microRNA-26a/b in the modulation of novel cancer pathways

(2015) I Fukumoto et al.   BRITISH JOURNAL OF CANCER

Tumour-suppressive microRNA-144-5p directly targets CCNE1/2 as potential prognostic markers in bladder cancer

(2015) R Matsushita et al.   BRITISH JOURNAL OF CANCER

Cancer statistics, 2015

(2015) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Tumor-suppressivemicroRNA-223inhibits cancer cell migration and invasion by targetingITGA3/ITGB1signaling in prostate cancer

(2015) Akira Kurozumi et al.   CANCER SCIENCE

Activation of EZH2 and SUZ12 Regulated by E2F1 Predicts the Disease Progression and Aggressive Characteristics of Bladder Cancer

(2015) S.-R. Lee et al.   CLINICAL CANCER RESEARCH

The MicroRNA Expression Signature of Bladder Cancer by Deep Sequencing: The Functional Significance of the miR-195/497 Cluster

(2014) Toshihiko Itesako et al.   PLoS One

miR-223 Is a Coordinator of Breast Cancer Progression as Revealed by Bioinformatics Predictions

(2014) Eva Maria Pinatel et al.   PLoS One

miR-223: infection, inflammation and cancer

(2013) M. Haneklaus et al.   JOURNAL OF INTERNAL MEDICINE

miRNA*: A Passenger Stranded in RNA-Induced Silencing Complex?

(2012) S. M. Mah et al.   CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION

A Systematic Review of Neoadjuvant and Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer

(2012) Joshua J. Meeks et al.   EUROPEAN UROLOGY

microRNAs in cancer management

(2012) Yi W Kong et al.   LANCET ONCOLOGY

Expression Signature of E2F1 and Its Associated Genes Predict Superficial to Invasive Progression of Bladder Tumors

(2010) Ju-Seog Lee et al.   JOURNAL OF CLINICAL ONCOLOGY

MicroRNAs: Target Recognition and Regulatory Functions

(2009) David P. Bartel   CELL

Most mammalian mRNAs are conserved targets of microRNAs

(2008) R. C. Friedman et al.   GENOME RESEARCH

Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?

(2008) Witold Filipowicz et al.   NATURE REVIEWS GENETICS

Gene Regulation by Transcription Factors and MicroRNAs

(2008) O. Hobert   SCIENCE